Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.75
-2.71 (-15.52%)
At close: Dec 5, 2025, 4:00 PM EST
14.79
+0.04 (0.27%)
After-hours: Dec 5, 2025, 7:58 PM EST
Adaptive Biotechnologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,252 | 885 | 709 | 1,093 | 3,960 | 8,087 | |
| Market Cap Growth | 240.59% | 24.72% | -35.07% | -72.41% | -51.03% | 117.39% | |
| Enterprise Value | 2,249 | 842 | 569 | 798 | 3,441 | 7,282 | |
| Last Close Price | 14.75 | 6.00 | 4.90 | 7.64 | 28.06 | 59.13 | |
| PS Ratio | 8.77 | 4.94 | 4.17 | 5.90 | 25.66 | 82.20 | |
| PB Ratio | 11.01 | 4.37 | 2.30 | 2.35 | 6.56 | 10.88 | |
| P/TBV Ratio | 27.03 | 11.02 | 3.85 | 3.23 | 8.31 | 13.17 | |
| EV/Sales Ratio | 8.90 | 4.70 | 3.34 | 4.31 | 22.29 | 74.02 | |
| Debt / Equity Ratio | 1.05 | 1.10 | 0.74 | 0.50 | 0.19 | 0.14 | |
| Asset Turnover | 0.48 | 0.30 | 0.22 | 0.21 | 0.15 | 0.10 | |
| Inventory Turnover | 8.07 | 7.79 | 6.65 | 4.48 | 11.50 | 11.98 | |
| Quick Ratio | 3.11 | 2.71 | 4.38 | 4.91 | 3.27 | 6.66 | |
| Current Ratio | 3.38 | 2.89 | 4.66 | 5.12 | 3.54 | 6.91 | |
| Return on Equity (ROE) | -37.21% | -62.49% | -58.34% | -37.52% | -30.77% | -22.25% | |
| Return on Assets (ROA) | -9.32% | -16.18% | -16.60% | -14.06% | -12.81% | -9.42% | |
| Return on Capital (ROIC) | -11.29% | -20.17% | -20.40% | -17.71% | -16.67% | -13.10% | |
| Return on Capital Employed (ROCE) | -19.20% | -35.20% | -35.20% | -26.80% | -25.80% | -15.10% | |
| Earnings Yield | -3.54% | -18.03% | -31.75% | -18.32% | -5.23% | -1.81% | |
| FCF Yield | -2.79% | -11.18% | -23.54% | -18.33% | -6.43% | -2.08% | |
| Buyback Yield / Dilution | -2.70% | -1.88% | -1.31% | -1.54% | -6.96% | -89.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.